Fort Point Capital Partners’s Biogen BIIB Stock Holding History

Fort Point Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,000	Closed	-$707K	–	151
2018 Q3	$707K	Buy	+2,000	New	+$689K	0.21%	63

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fort Point Capital Partners's BIIB Position: Q4 2014 in Review

Fort Point Capital Partners sold out of Biogen (BIIB) in Q4 2014, closing a stake of 800 shares — an estimated $265K sold.

Fort Point Capital Partners first reported a position in BIIB in Q3 2014 and held it in 1 quarter. The position peaked at $265K in Q3 2014. 885 funds tracked by Wall St. Rank hold BIIB as of Q4 2014.

Fort Point Capital Partners reported no remaining Biogen position as of Q4 2014 after selling out during the quarter.
Fort Point Capital Partners sold 800 Biogen shares in Q4 2014, an estimated $265K.
Fort Point Capital Partners first reported a position in Biogen in Q3 2014 and held it in 1 quarter.
Fort Point Capital Partners's Biogen position peaked at $265K in Q3 2014.
885 funds tracked by Wall St. Rank held Biogen as of Q4 2014.

Based on Fort Point Capital Partners's 13F filing for Q4 2014, filed 18 Feb 2015.